{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:12:46Z","timestamp":1782789166785,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1124\/dmd.123.001496","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T18:00:18Z","timestamp":1696010418000},"page":"1651-1662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes"],"prefix":"10.1016","volume":"51","author":[{"given":"Xue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-6277","authenticated-orcid":false,"given":"Fengling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001496_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00418-022-02086-0","article-title":"A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice","volume":"157","author":"Abu-Dief","year":"2022","journal-title":"Histochem Cell Biol"},{"key":"10.1124\/dmd.123.001496_bib2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"10.1124\/dmd.123.001496_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2010.12.005","article-title":"Prodrug-based intracellular delivery of anticancer agents","volume":"63","author":"Bildstein","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.123.001496_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/dmd.118.084509","article-title":"Suppression of Hepatic CYP3A4 Expression and Activity by 3-Methylcholanthrene in Humanized PXR-CAR-CYP3A4\/3A7 Mice","volume":"47","author":"Crosby","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001496_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00204-021-03204-y","article-title":"Cardiotoxicity of cyclophosphamide\u2019s metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes","volume":"96","author":"Dion\u00edsio","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.123.001496_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2020.04.011","article-title":"Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon","volume":"323","author":"El Sayed","year":"2020","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13318-019-00595-3","article-title":"Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients","volume":"45","author":"Flannery","year":"2020","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.123.001496_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.123.001496_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1124\/jpet.107.120303","article-title":"Antiepileptic drugs affect neuronal androgen signaling via a cytochrome P450-dependent pathway","volume":"322","author":"Gehlhaus","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.123.001496_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front Immunol"},{"key":"10.1124\/dmd.123.001496_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jchromb.2018.04.016","article-title":"A sensitive and rapid ultra high-performance liquid chromatography with tandem mass spectrometric assay for the simultaneous quantitation of cyclophosphamide and the 4-hydroxycyclophosphamide metabolite in human plasma","volume":"1086","author":"Hall","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.123.001496_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2020.05.004","article-title":"Cortex dictamni-induced liver injury in mice: The role of P450-mediated metabolic activation of furanoids","volume":"330","author":"Huang","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.123.001496_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: A mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib15","doi-asserted-by":"crossref","first-page":"17955","DOI":"10.1021\/acsami.6b05840","article-title":"Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease","volume":"8","author":"Im","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1124\/dmd.123.001496_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.08.017","article-title":"Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection","volume":"115","author":"Ishida","year":"2006","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib18","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s11095-009-9943-x","article-title":"Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles","volume":"26","author":"Ishihara","year":"2009","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001496_bib19","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/biomedicines10112686","article-title":"The Role of CYP3A in Health and Disease","volume":"10","author":"Klyushova","year":"2022","journal-title":"Biomedicines"},{"key":"10.1124\/dmd.123.001496_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2010.03.022","article-title":"T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes","volume":"392","author":"Koide","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.123.001496_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.123.001496_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","author":"Ladd","year":"2023","journal-title":"Hepatology"},{"key":"10.1124\/dmd.123.001496_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2217\/pgs-2019-0094","article-title":"CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinoma","volume":"20","author":"Lauschke","year":"2019","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.123.001496_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)29419-2","article-title":"Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection","volume":"298","author":"Laverman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.123.001496_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2013.01.012","article-title":"Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan","volume":"443","author":"Li","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.123.001496_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/dmd.123.001496_bib27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.30917","article-title":"Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-\u03baB\/Snail Signaling Pathway and Epithelial-Mesenchymal Transition","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1124\/dmd.123.001496_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jconrel.2021.12.025","article-title":"A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions.","volume":"343","author":"Liu","year":"2022","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121365","article-title":"Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions","volume":"612","author":"Liu","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.123.001496_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1124\/dmd.123.001496_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115138","article-title":"1H NMR-based urinary metabolic analysis of high-dose cyclophosphamide-induced toxicity in mice","volume":"670","author":"Luo","year":"2023","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.123.001496_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.123.001496_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00210-021-02182-3","article-title":"Protective effects of berberine as a natural antioxidant and anti-inflammatory agent against nephrotoxicity induced by cyclophosphamide in mice","volume":"395","author":"Mombeini","year":"2022","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/dmd.123.001496_bib34","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.123.001496_bib35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001496_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123228","article-title":"Cyclophosphamide, hydroxycyclophosphamide and carboxyethyl phosphoramide mustard quantification with liquid chromatography mass spectrometry in a single run human plasma samples: A rapid and sensitive method development","volume":"1198","author":"Shanker Kasudhan","year":"2022","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.123.001496_bib37","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.3390\/cancers14122868","article-title":"An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment","volume":"14","author":"Sharifi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1124\/dmd.123.001496_bib38","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1124\/dmd.123.001496_bib39","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1124\/dmd.123.001496_bib40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.imbio.2015.06.005","article-title":"Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells","volume":"220","author":"Shimizu","year":"2015","journal-title":"Immunobiology"},{"key":"10.1124\/dmd.123.001496_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2016.05.010","article-title":"Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance","volume":"234","author":"Shiraishi","year":"2016","journal-title":"J Control Release"},{"key":"10.1124\/dmd.123.001496_bib42","first-page":"44","article-title":"The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin","volume":"13","author":"Su","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"10.1124\/dmd.123.001496_bib43","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.07.049","article-title":"Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs","volume":"436","author":"Suzuki","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.123.001496_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2014.09.047","article-title":"Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin","volume":"476","author":"Suzuki","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.123.001496_bib45","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/dmd.32.8.834","article-title":"Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes","volume":"32","author":"Turncliff","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001496_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2017.06.013","article-title":"Prodrugs in medicinal chemistry and enzyme prodrug therapies","volume":"118","author":"Walther","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.123.001496_bib47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/dmd.119.086769","article-title":"Activation of Pregnane X Receptor-Cytochrome P450s Axis: A Possible Reason for the Enhanced Accelerated Blood Clearance Phenomenon of PEGylated Liposomes In Vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001496_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/dmd.118.085340","article-title":"Induction of Cytochrome P450 Involved in the Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomes In Vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001496_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/dmd.122.001131","article-title":"Activation\/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer Therapy","volume":"51","author":"Wang","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001496_bib50","first-page":"250","article-title":"Effects of complement inhibition on the ABC phenomenon in rats","volume":"12","author":"Wang","year":"2017","journal-title":"Asian J Pharm Sci"},{"key":"10.1124\/dmd.123.001496_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2016.04.019","article-title":"ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1\u03b1","volume":"65","author":"Wu","year":"2016","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.123.001496_bib52","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","article-title":"A targetable LIFR-NF-\u03baB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis","volume":"12","author":"Yao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/dmd.123.001496_bib53","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2147\/CMAR.S159425","article-title":"The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma","volume":"10","author":"Yu","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1124\/dmd.123.001496_bib54","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1172\/JCI137553","article-title":"Hypoxia-inducible factors and innate immunity in liver cancer","volume":"130","author":"Yuen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.123.001496_bib55","first-page":"134","article-title":"The effect of monosialylganglioside mix modifying the PEGylated liposomal epirubicin on the accelerated blood clearance phenomenon","volume":"12","author":"Zhang","year":"2017","journal-title":"Asian J Pharm Sci"},{"key":"10.1124\/dmd.123.001496_bib56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2020.12.047","article-title":"Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines.","volume":"330","author":"Zhang","year":"2021","journal-title":"J Controlled Release"},{"key":"10.1124\/dmd.123.001496_bib57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejpb.2012.04.023","article-title":"A frustrating problem: accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats","volume":"81","author":"Zhao","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/dmd.123.001496_bib58","first-page":"2891","article-title":"Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles","volume":"7","author":"Zhao","year":"2012","journal-title":"Int J Nanomedicine"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:06:36Z","timestamp":1739955996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624011036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0090955624011036"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001496","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}